US Patent Issued to SYSVAX on Aug. 26 for "Nano antibody for neutralizing toxicity of SARS-CoV-2 and preparation method and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,199, issued on Aug. 26, was assigned to SYSVAX INC (Guangdong, China).

"Nano antibody for neutralizing toxicity of SARS-CoV-2 and preparation method and application thereof" was invented by Wenchao Zhuang (Zhongshan, China), Fusheng Li (Zhongshan, China), Qianhui Li (Zhongshan, China), Zhi Ling (Zhongshan, China) and Yunxing Zhao (Zhongshan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure discloses a nano antibody for neutralizing a toxicity of SARS-CoV-2 and preparation method thereof. The nano antibody comprises a complementarity determining region CDR comprising a CDR1, a CDR2 and a CDR3; an amino acid sequence of the ...